Global private equity firm CVC Capital Partners (CVC) has acquired a majority interest in Health action company Icario, through the CVC Growth Partners II fund.
Financial terms of the investment, which will be used to fuel Icario’s next phase of growth, have not been disclosed.
Having rebranded earlier this year following the merger of market leaders Revel and NovuHealth, CVC will now help Icario accelerate its business roadmap as it continues to build innovative solutions for its customers, which include many of the most trusted health plans in the United States.
Source: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.